BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 12100413)

  • 1. Fetal cardiac abnormalities identified prior to 14 weeks' gestation.
    Huggon IC; Ghi T; Cook AC; Zosmer N; Allan LD; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):22-9. PubMed ID: 12100413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency.
    Lopes LM; Brizot ML; Lopes MA; Ayello VD; Schultz R; Zugaib M
    Ultrasound Obstet Gynecol; 2003 Nov; 22(5):470-8. PubMed ID: 14618659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal echocardiography at the time of the nuchal translucency scan.
    Lombardi CM; Bellotti M; Fesslova V; Cappellini A
    Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the first-trimester cardiac scan by ultrasound-trained obstetricians with high-frequency transabdominal probes in fetuses with increased nuchal translucency.
    Bellotti M; Fesslova V; De Gasperi C; Rognoni G; Bee V; Zucca I; Cappellini A; Bulfamante G; Lombardi CM
    Ultrasound Obstet Gynecol; 2010 Sep; 36(3):272-8. PubMed ID: 20499407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy.
    Smrcek JM; Gembruch U; Krokowski M; Berg C; Krapp M; Geipel A; Germer U
    Arch Gynecol Obstet; 2003 Jun; 268(2):94-101. PubMed ID: 12768297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation.
    Galindo A; Comas C; Martínez JM; Gutiérrez-Larraya F; Carrera JM; Puerto B; Borrell A; Mortera C; de la Fuente P
    J Matern Fetal Neonatal Med; 2003 Mar; 13(3):163-70. PubMed ID: 12820838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester tricuspid regurgitation and fetal abnormalities.
    Wiechec M; Nocun A; Wiercinska E; Beithon J; Knafel A
    J Perinat Med; 2015 Sep; 43(5):597-603. PubMed ID: 24799402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
    Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
    Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
    Matias A; Huggon I; Areias JC; Montenegro N; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Nov; 14(5):307-10. PubMed ID: 10623988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies.
    Carvalho JS; Moscoso G; Tekay A; Campbell S; Thilaganathan B; Shinebourne EA
    Heart; 2004 Aug; 90(8):921-6. PubMed ID: 15253970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.
    Michailidis GD; Economides DL
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):102-5. PubMed ID: 11251915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.